Parallel manifestations of neuropathologies in the enteric and central nervous systems

G. Natale, L. Pasquali, A. Paparelli, F. Fornai

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background Neurodegenerative diseases may extend outside the central nervous system (CNS) and involve the gastrointestinal (GI) tract. The gut would appear to be a pathological marker for neurodegeneration, as well as a site for studying the pathophysiology of neurodegeneration. In fact, both in the ENS and CNS, misfolded proteins are likely to initiate a process of neurodegeneration. For example, the very same protein aggregates can be detected both in the ENS and CNS. In both systems, misfolded proteins are likely to share common cell-to-cell diffusion mechanisms, which may occur through a parallel prion-like diffusion process. Independently from the enteric or central origin, misfolded proteins may proceed along the following steps, they: (i) form aggregates; (ii) are expressed on plasma membrane; (iii) are secreted extracellularly; (iv) are glycated to form advanced glycation end-products (AGEs); (v) are internalized through specific receptors placed on neighboring cells (RAGEs); (vi) are cleared by autophagy; and (vii) are neurotoxic. These features are common for a-synuclein (in Parkinson's disease and other synucleinopathies), β-amyloid and tau (in degenerative dementia), SOD-1 and TDP43 (in amyotrophic lateral sclerosis), and PrPsc (in prion diseases). While in some diseases these features are common to both ENS and CNS, in others this remains a working hypothesis. Purpose This review analyzes GI alterations from a pathological perspective to assess whether the enteric nervous system (ENS) mirrors the neuropathology described in the CNS. We discuss the potential mechanisms that lead to the onset and spread of neurodegeneration within the gut, from the gut to the brain, and vice versa.

Original languageEnglish
Pages (from-to)1056-1065
Number of pages10
JournalNeurogastroenterology and Motility
Volume23
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Enteric Nervous System
Central Nervous System
Synucleins
Advanced Glycosylation End Products
Proteins
Prion Diseases
Prions
Autophagy
Amyotrophic Lateral Sclerosis
Amyloid
Neurodegenerative Diseases
Parkinson Disease
Dementia
Gastrointestinal Tract
Cell Membrane
Neuropathology
Brain

Keywords

  • Autonomic nervous system
  • Gastrointestinal tract
  • Neurodegenerative diseases
  • Prion disease
  • Synucleinopathies

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Gastroenterology
  • Physiology

Cite this

Parallel manifestations of neuropathologies in the enteric and central nervous systems. / Natale, G.; Pasquali, L.; Paparelli, A.; Fornai, F.

In: Neurogastroenterology and Motility, Vol. 23, No. 12, 12.2011, p. 1056-1065.

Research output: Contribution to journalArticle

Natale, G. ; Pasquali, L. ; Paparelli, A. ; Fornai, F. / Parallel manifestations of neuropathologies in the enteric and central nervous systems. In: Neurogastroenterology and Motility. 2011 ; Vol. 23, No. 12. pp. 1056-1065.
@article{701510100471460cac99fd27c49f09e7,
title = "Parallel manifestations of neuropathologies in the enteric and central nervous systems",
abstract = "Background Neurodegenerative diseases may extend outside the central nervous system (CNS) and involve the gastrointestinal (GI) tract. The gut would appear to be a pathological marker for neurodegeneration, as well as a site for studying the pathophysiology of neurodegeneration. In fact, both in the ENS and CNS, misfolded proteins are likely to initiate a process of neurodegeneration. For example, the very same protein aggregates can be detected both in the ENS and CNS. In both systems, misfolded proteins are likely to share common cell-to-cell diffusion mechanisms, which may occur through a parallel prion-like diffusion process. Independently from the enteric or central origin, misfolded proteins may proceed along the following steps, they: (i) form aggregates; (ii) are expressed on plasma membrane; (iii) are secreted extracellularly; (iv) are glycated to form advanced glycation end-products (AGEs); (v) are internalized through specific receptors placed on neighboring cells (RAGEs); (vi) are cleared by autophagy; and (vii) are neurotoxic. These features are common for a-synuclein (in Parkinson's disease and other synucleinopathies), β-amyloid and tau (in degenerative dementia), SOD-1 and TDP43 (in amyotrophic lateral sclerosis), and PrPsc (in prion diseases). While in some diseases these features are common to both ENS and CNS, in others this remains a working hypothesis. Purpose This review analyzes GI alterations from a pathological perspective to assess whether the enteric nervous system (ENS) mirrors the neuropathology described in the CNS. We discuss the potential mechanisms that lead to the onset and spread of neurodegeneration within the gut, from the gut to the brain, and vice versa.",
keywords = "Autonomic nervous system, Gastrointestinal tract, Neurodegenerative diseases, Prion disease, Synucleinopathies",
author = "G. Natale and L. Pasquali and A. Paparelli and F. Fornai",
year = "2011",
month = "12",
doi = "10.1111/j.1365-2982.2011.01794.x",
language = "English",
volume = "23",
pages = "1056--1065",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Parallel manifestations of neuropathologies in the enteric and central nervous systems

AU - Natale, G.

AU - Pasquali, L.

AU - Paparelli, A.

AU - Fornai, F.

PY - 2011/12

Y1 - 2011/12

N2 - Background Neurodegenerative diseases may extend outside the central nervous system (CNS) and involve the gastrointestinal (GI) tract. The gut would appear to be a pathological marker for neurodegeneration, as well as a site for studying the pathophysiology of neurodegeneration. In fact, both in the ENS and CNS, misfolded proteins are likely to initiate a process of neurodegeneration. For example, the very same protein aggregates can be detected both in the ENS and CNS. In both systems, misfolded proteins are likely to share common cell-to-cell diffusion mechanisms, which may occur through a parallel prion-like diffusion process. Independently from the enteric or central origin, misfolded proteins may proceed along the following steps, they: (i) form aggregates; (ii) are expressed on plasma membrane; (iii) are secreted extracellularly; (iv) are glycated to form advanced glycation end-products (AGEs); (v) are internalized through specific receptors placed on neighboring cells (RAGEs); (vi) are cleared by autophagy; and (vii) are neurotoxic. These features are common for a-synuclein (in Parkinson's disease and other synucleinopathies), β-amyloid and tau (in degenerative dementia), SOD-1 and TDP43 (in amyotrophic lateral sclerosis), and PrPsc (in prion diseases). While in some diseases these features are common to both ENS and CNS, in others this remains a working hypothesis. Purpose This review analyzes GI alterations from a pathological perspective to assess whether the enteric nervous system (ENS) mirrors the neuropathology described in the CNS. We discuss the potential mechanisms that lead to the onset and spread of neurodegeneration within the gut, from the gut to the brain, and vice versa.

AB - Background Neurodegenerative diseases may extend outside the central nervous system (CNS) and involve the gastrointestinal (GI) tract. The gut would appear to be a pathological marker for neurodegeneration, as well as a site for studying the pathophysiology of neurodegeneration. In fact, both in the ENS and CNS, misfolded proteins are likely to initiate a process of neurodegeneration. For example, the very same protein aggregates can be detected both in the ENS and CNS. In both systems, misfolded proteins are likely to share common cell-to-cell diffusion mechanisms, which may occur through a parallel prion-like diffusion process. Independently from the enteric or central origin, misfolded proteins may proceed along the following steps, they: (i) form aggregates; (ii) are expressed on plasma membrane; (iii) are secreted extracellularly; (iv) are glycated to form advanced glycation end-products (AGEs); (v) are internalized through specific receptors placed on neighboring cells (RAGEs); (vi) are cleared by autophagy; and (vii) are neurotoxic. These features are common for a-synuclein (in Parkinson's disease and other synucleinopathies), β-amyloid and tau (in degenerative dementia), SOD-1 and TDP43 (in amyotrophic lateral sclerosis), and PrPsc (in prion diseases). While in some diseases these features are common to both ENS and CNS, in others this remains a working hypothesis. Purpose This review analyzes GI alterations from a pathological perspective to assess whether the enteric nervous system (ENS) mirrors the neuropathology described in the CNS. We discuss the potential mechanisms that lead to the onset and spread of neurodegeneration within the gut, from the gut to the brain, and vice versa.

KW - Autonomic nervous system

KW - Gastrointestinal tract

KW - Neurodegenerative diseases

KW - Prion disease

KW - Synucleinopathies

UR - http://www.scopus.com/inward/record.url?scp=81855185603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855185603&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2982.2011.01794.x

DO - 10.1111/j.1365-2982.2011.01794.x

M3 - Article

C2 - 21951862

AN - SCOPUS:81855185603

VL - 23

SP - 1056

EP - 1065

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 12

ER -